Therapeutic hypothermia attenuates tissue damage and cytokine expression after traumatic brain injury by inhibiting necroptosis in the rat

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Tao ^a   Zhao, Dong Xu ^a   Cui, Hua ^a   Chen, Lei ^b   Bao, Ying Hui ^a   Wang, Yong ^a   Jiang, Ji Yao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b People's Hospital of Pudong New Area   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; CYTOKINE; MESSENGER RNA;

ANIMAL; APOPTOSIS; BRAIN CORTEX; BRAIN INJURIES, TRAUMATIC; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPAL CA1 REGION; INDUCED HYPOTHERMIA; MALE; METABOLISM; NECROSIS; PATHOLOGY; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; APOPTOSIS; BIOMARKERS; BRAIN INJURIES, TRAUMATIC; CA1 REGION, HIPPOCAMPAL; CEREBRAL CORTEX; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPOTHERMIA, INDUCED; INFLAMMATION MEDIATORS; MALE; NECROSIS; PYRAMIDAL CELLS; RATS; RNA, MESSENGER;

EID: 84964199296     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24547     Document Type: Article

References (57)

1. Corps, K. N., Roth, T. L. & McGavern, D. B. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 72, 355-362 (2015).
2. Cohen-Yeshurun, A. et al. N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis. J Cereb Blood Flow Metab. 31, 1768-1777 (2011).
3. Lai, Y. et al. Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gammaglutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab. 28, 540-550 (2008).
4. Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 1, 112-119 (2005).
5. Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature. 517, 311-320 (2015).
6. Longhi, L. et al. Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor. J Cereb Blood Flow Metab. 33, 1182-1189 (2013).
7. Khuman, J. et al. Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. J Cereb Blood Flow Metab. 31, 778-789 (2011).
8. Varfolomeev, E. E. & Ashkenazi, A. Tumor necrosis factor: an apoptosis JuNKie? Cell. 116, 491-497 (2004).
9. Vandenabeele, P., Galluzzi, L., Vanden Berghe, T. & Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 11, 700-714 (2010).
10. Li, J. et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell. 150, 339-350 (2012).
11. Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 325, 332-336 (2009).
12. Orozco, S. et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ. 21, 1511-1521 (2014).
13. Wu, X. N. et al. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ. 21, 1709-1720 (2014).
14. Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity. 39, 443-453 (2013).
15. Galluzzi, L., Kepp, O. & Kroemer, G. MLKL regulates necrotic plasma membrane permeabilization. Cell Res. 24, 139-140 (2014).
16. O'Donnell, M. A. et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol. 13, 1437-1442 (2011).
17. Trichonas, G. et al. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc. Natl. Acad. Sci. USA 107, 21695-21700 (2010).
18. You, Z. et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 28, 1564-1573 (2008).
19. Wang, Y. Q. et al. Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model. Neurochem Res. 37, 1849-1858 (2012).
20. Jouan-Lanhouet, S. et al. Necroptosis, in vivo detection in experimental disease models. Semin Cell Dev Biol. 35, 2-13 (2014).
21. Luedde, M. et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res. 103, 206-216 (2014).
22. Bonnet, M. C. et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35, 572-582 (2011).
23. Dietrich, W. D. & Bramlett, H. M. The evidence for hypothermia as a neuroprotectant in traumatic brain injury. Neurotherapeutics 7, 43-50 (2010).
24. Dietrich, W. D. et al. Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol. 87, 250-258 (1994).
25. Dixon, C. E. et al. Protective effects of moderate hypothermia on behavioral deficits but not necrotic cavitation following cortical impact injury in the rat. J Neurotrauma 15, 95-103 (1998).
26. Clifton, G. L., Allen, S., Berry, J. & Koch, S. M. Systemic hypothermia in treatment of brain injury. J Neurotrauma 9, Suppl 2, S487-495 (1992).
27. Kim, J. H., Seo, M. & Suk, K. Effects of therapeutic hypothermia on the glial proteome and phenotype. Curr Protein Pept Sci. 14, 51-60 (2013).
28. Yenari, M. A. & Han, H. S. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci. 13, 267-278 (2012).
29. Zimmermann, M. Ethical Guidelines for investigations of Experimental Pain in Conscious Animals. Pain. 16, 109-110 (1983).
30. Jia, F. et al. Matrix metalloproteinase-9 expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. J Neurotrauma. 27, 1059-1068 (2010).
31. Bao, Y. H. et al. Post-traumatic seizures exacerbate histopathological damage after fluid-percussion brain injury. J Neurotrauma. 28, 35-42 (2011).
32. Yin, B. et al. Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion. Brain Res. doi: 10.1016/j. brainres.2015.03.024 (2015).
33. Raghupathi, R., Graham, D. I. & McIntosh, T. K. Apoptosis after traumatic brain injury. J Neurotrauma. 17, 927-938 (2000).
34. Andersen, J. L. & Kornbluth, S. The tangled circuitry of metabolism and apoptosis. Mol Cell. 49, 399-410 (2013).
35. Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell. 133, 693-703 (2008).
36. Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 1, 489-495 (2000).
37. Sutton, R. L., Lescaudron, L. & Stein, D. G. Unilateral cortical contusion injury in the rat: vascular disruption and temporal development of cortical necrosis. J Neurotrauma. 10, 135-149 (1993).
38. Vieira, M. et al. Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3. Neurobiol Dis. 68, 26-36 (2014).
39. Linkermann, A. et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int. 81, 751-761 (2012).
40. Jia, F., Mao, Q., Liang, Y. M. & Jiang, J. Y. Effect of post-traumatic mild hypothermia on hippocampal cell death after traumatic brain injury in rats. J Neurotrauma. 26, 243-252 (2009).
41. Feng, M. et al. Protective effects of necrostatin-1 on glucocorticoid-induced osteoporosis in rats. J Steroid Biochem Mol Biol. 144, Pt B, 455-462 (2014).
42. Chan, F. K. Fueling the flames: Mammalian programmed necrosis in inflammatory diseases. Cold Spring Harb Perspect Biol. doi: 10.1101/cshperspect.a008805 (2012).
43. Moujalled, D. M. et al. TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Cell Death Dis. 4, e465 (2013).
44. Newton, K. et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science. 343, 1357-1360 (2014).
45. Mandal, P. et al. RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity. Mol Cell. 56, 481-495 (2014).
46. Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 148, 213-227 (2012).
47. Urbano, L. A. & Oddo, M. Therapeutic hypothermia for traumatic brain injury. Curr Neurol Neurosci Rep. 12, 580-591 (2012).
48. Lotocki, G. et al. Therapeutic hypothermia modulates TNFR1 signaling in the traumatized brain via early transient activation of the JNK pathway and suppression of XIAP cleavage. Eur J Neurosci. 24, 2283-2290 (2006).
49. Fritz, H. G. & Bauer, R. Traumatic injury in the developing brain-effects of hypothermia. Exp Toxicol Pathol. 56, 91-102 (2004).
50. Murakami, Y. et al. Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ 21, 270-277 (2014).
51. He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 137, 1100-1111 (2009).
52. Wu, J. et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23, 994-1006 (2013).
53. Vitner, E. B. et al. RIPK3 as a potential therapeutic target for Gaucher's disease. Nat Med. 20, 204-208 (2014).
54. Linkermann, A. et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 110, 12024-12029 (2013).
55. Kanakura, H. & Taniguchi, T. The antiinflammatory effects of propofol in endotoxemic rats during moderate and mild hypothermia. J Anesth. 21, 354-360 (2007).
56. Okuma, Y. et al. Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann Neurol. 72, 373-384 (2012).
57. Yatsiv, I. et al. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab. 22, 971-978 (2002).